The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

HER2 Routine Nears Two-12 months Illness Management in Gastroesophageal Most cancers

A brand new HER2-targeted routine could push survival nearer to 2 years for some sufferers with gastroesophageal most cancers, in response to...

Discussing Bonds and Empathy within the Childhood Most cancers Group

Joe McDonough has devoted almost twenty years to supporting youngsters with most cancers and their households by means of The Andrew McDonough...

Understanding High quality of Life Priorities in Later-Line Colon Most cancers

Dr. Thejus Jayakrishnan sat down with CURE on the 2026 ASCO Gastrointestinal Cancers Symposium to debate analysis he offered evaluating how sufferers...

A Decade of Affected person Proactivity and Doctor Partnership

Mayra Andujar-Delgado is grateful to her doctor, Dr. Faseeh Khaja, for the way he saved each her and her caregiver, which was...

FDA Utility Submitted for Rusfertide Therapy in Polycythemia Vera

Takeda and Protagonist Therapeutics have introduced the submission of a brand new drug software to the U.S. Meals and Drug Administration (FDA),...

Hot Topics